1
|
Yan J, Bhanshali F, Shuzenji C, Mendenhall TT, Taylor SKB, Ermakova G, Cheng X, Bai P, Diwan G, Seraj D, Meyer JN, Sorensen PH, Hartman JH, Taubert S. Eukaryotic Elongation Factor 2 Kinase EFK-1/eEF2K promotes starvation resistance by preventing oxidative damage in C. elegans. Nat Commun 2025; 16:1752. [PMID: 39966347 PMCID: PMC11836464 DOI: 10.1038/s41467-025-56766-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2024] [Accepted: 01/29/2025] [Indexed: 02/20/2025] Open
Abstract
Cells and organisms frequently experience starvation. To survive, they mount an evolutionarily conserved stress response. A vital component in the mammalian starvation response is eukaryotic elongation factor 2 (eEF2) kinase (eEF2K), which suppresses translation in starvation by phosphorylating and inactivating the translation elongation driver eEF2. C. elegans EFK-1/eEF2K phosphorylates EEF-2/eEF2 on a conserved residue and is required for starvation survival, but how it promotes survival remains unclear. Surprisingly, we found that eEF2 phosphorylation is unchanged in starved C. elegans and EFK-1's kinase activity is dispensable for starvation survival, suggesting that efk-1 promotes survival via a noncanonical pathway. We show that efk-1 upregulates transcription of DNA repair pathways, nucleotide excision repair (NER) and base excision repair (BER), to promote starvation survival. Furthermore, efk-1 suppresses oxygen consumption and ROS production in starvation to prevent oxidative stress. Thus, efk-1 enables starvation survival by protecting animals from starvation-induced oxidative damage through an EEF-2-independent pathway.
Collapse
Affiliation(s)
- Junran Yan
- Centre for Molecular Medicine and Therapeutics, The University of British Columbia, 950 W 28 th Ave, Vancouver, BC, V5Z 4H4, Canada
- Edwin S.H. Leong Centre for Healthy Aging, The University of British Columbia, 117-2194 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada
- British Columbia Children's Hospital Research Institute, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
- Graduate Program in Cell & Developmental Biology, The University of British Columbia, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
| | - Forum Bhanshali
- Centre for Molecular Medicine and Therapeutics, The University of British Columbia, 950 W 28 th Ave, Vancouver, BC, V5Z 4H4, Canada
- British Columbia Children's Hospital Research Institute, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
- Department of Medical Genetics, The University of British Columbia, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
- Catalera BioSolutions, 199 W 6th Ave, Vancouver, BC, V5Y 1K3, Canada
| | - Chiaki Shuzenji
- Centre for Molecular Medicine and Therapeutics, The University of British Columbia, 950 W 28 th Ave, Vancouver, BC, V5Z 4H4, Canada
- Edwin S.H. Leong Centre for Healthy Aging, The University of British Columbia, 117-2194 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada
- British Columbia Children's Hospital Research Institute, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
- Department of Medical Genetics, The University of British Columbia, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
| | - Tsultrim T Mendenhall
- Department of Biochemistry and Molecular Biology, Medical University of South Carolina, 173 Ashley Ave, Charleston, SC, 29425, USA
| | - Shane K B Taylor
- Centre for Molecular Medicine and Therapeutics, The University of British Columbia, 950 W 28 th Ave, Vancouver, BC, V5Z 4H4, Canada
- Edwin S.H. Leong Centre for Healthy Aging, The University of British Columbia, 117-2194 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada
- British Columbia Children's Hospital Research Institute, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
- Department of Medical Genetics, The University of British Columbia, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
| | - Glafira Ermakova
- Centre for Molecular Medicine and Therapeutics, The University of British Columbia, 950 W 28 th Ave, Vancouver, BC, V5Z 4H4, Canada
- Edwin S.H. Leong Centre for Healthy Aging, The University of British Columbia, 117-2194 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada
- British Columbia Children's Hospital Research Institute, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
- Department of Medical Genetics, The University of British Columbia, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
| | - Xuanjin Cheng
- Centre for Molecular Medicine and Therapeutics, The University of British Columbia, 950 W 28 th Ave, Vancouver, BC, V5Z 4H4, Canada
- British Columbia Children's Hospital Research Institute, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
- Department of Medical Genetics, The University of British Columbia, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
- Canada's Michael Smith Genome Sciences Centre, 570 W 7th Ave, Vancouver, BC, V5Z 4S6, Canada
| | - Pamela Bai
- Centre for Molecular Medicine and Therapeutics, The University of British Columbia, 950 W 28 th Ave, Vancouver, BC, V5Z 4H4, Canada
- Edwin S.H. Leong Centre for Healthy Aging, The University of British Columbia, 117-2194 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada
- British Columbia Children's Hospital Research Institute, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
- Department of Medical Genetics, The University of British Columbia, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
| | - Gahan Diwan
- Centre for Molecular Medicine and Therapeutics, The University of British Columbia, 950 W 28 th Ave, Vancouver, BC, V5Z 4H4, Canada
- British Columbia Children's Hospital Research Institute, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
- Department of Biology, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada
| | - Donna Seraj
- Centre for Molecular Medicine and Therapeutics, The University of British Columbia, 950 W 28 th Ave, Vancouver, BC, V5Z 4H4, Canada
- British Columbia Children's Hospital Research Institute, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
- Department of Medical Genetics, The University of British Columbia, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada
| | - Joel N Meyer
- Nicholas School of the Environment, Duke University, Durham, NC, 27708-0328, USA
| | - Poul H Sorensen
- Department of Pathology and Laboratory Medicine, University of British Columbia, 675 W 10th Ave, Vancouver, BC, V6T 1Z4, Canada
- Department of Molecular Oncology, BC Cancer Research Institute, 675 W 10th Ave, Vancouver, BC, V5Z 1L3, Canada
| | - Jessica H Hartman
- Department of Biochemistry and Molecular Biology, Medical University of South Carolina, 173 Ashley Ave, Charleston, SC, 29425, USA
| | - Stefan Taubert
- Centre for Molecular Medicine and Therapeutics, The University of British Columbia, 950 W 28 th Ave, Vancouver, BC, V5Z 4H4, Canada.
- Edwin S.H. Leong Centre for Healthy Aging, The University of British Columbia, 117-2194 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada.
- British Columbia Children's Hospital Research Institute, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada.
- Graduate Program in Cell & Developmental Biology, The University of British Columbia, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada.
- Department of Medical Genetics, The University of British Columbia, 950 W 28th Ave, Vancouver, BC, V5Z 4H4, Canada.
| |
Collapse
|
2
|
Hodgkin J, Stroud D, O'Rourke D. Mutations of nhr-49 affect C. elegans susceptibility to Yersinia biofilms. MICROPUBLICATION BIOLOGY 2025; 2025:10.17912/micropub.biology.001522. [PMID: 39975509 PMCID: PMC11836678 DOI: 10.17912/micropub.biology.001522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Figures] [Subscribe] [Scholar Register] [Received: 01/27/2025] [Revised: 02/03/2025] [Accepted: 02/03/2025] [Indexed: 02/21/2025]
Abstract
The C. elegans transcription factor NHR-49 has been extensively studied for its functions in regulating metabolic processes, stress responses, innate immunity and aging. Molecular identification of a gene previously known as bah-3 , which affects susceptibility of worms to deleterious surface attachment of bacterial biofilms from Yersinia spp., revealed that bah-3 ( dc9 ) is an ochre nonsense allele of nhr-49 . Other severe mutations of nhr-49 also had a Bah phenotype, but deletions affecting 5' isoforms of the gene did not affect biofilm attachment, nor did 3' gain-of-function missense mutations. Other bah genes ( bah-1 , bah-2 , bah-4 ) encode GT92 glycosylation factors, predicted to affect surface coat. NHR-49 may act as a positive transcription factor for one or more of these surface glycosylation genes, in contrast to its other roles in regulating metabolic processes.
Collapse
Affiliation(s)
- Jonathan Hodgkin
- Biochemistry, University of Oxford, Oxford, England, United Kingdom
| | - Dave Stroud
- Biochemistry, University of Oxford, Oxford, England, United Kingdom
| | - Delia O'Rourke
- Centre for Human Genetics, University of Oxford, Oxford, England, United Kingdom
| |
Collapse
|
3
|
Liu Z, Wang Y, Bian Q, Wang D. Transgenerational Response of Germline Nuclear Hormone Receptor Genes to Nanoplastics at Predicted Environmental Doses in Caenorhabditis elegans. TOXICS 2024; 12:420. [PMID: 38922100 PMCID: PMC11209457 DOI: 10.3390/toxics12060420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/15/2024] [Revised: 06/06/2024] [Accepted: 06/06/2024] [Indexed: 06/27/2024]
Abstract
Transgenerational nanoplastic toxicity could be detected in Caenorhabditis elegans after exposure at the parental generation (P0-G); however, the underlying mechanisms remain largely unclear. We aimed to examine the role of germline nuclear hormone receptors (NHRs) in controlling the transgenerational toxicity of polystyrene nanoparticles (PS-NPs) based on gene expression screening and functional analysis. Among germline NHR genes, daf-12, nhr-14, and nhr-47 expressions were increased and nhr-12 expression was decreased by PS-NPs (1 and 10 μg/L). Transgenerational alterations in expressions of these four NHR genes were also induced by PS-NPs (1 and 10 μg/L). RNAi of daf-12, nhr-14, and nhr-47 caused resistance, whereas RNAi of nhr-12 conferred susceptibility to transgenerational PS-NP toxicity. After PS-NP exposure, expressions of ins-3, daf-28, and ins-39 encoding insulin ligands, efn-3 encoding Ephrin ligand, and lin-44 encoding Wnt ligand, as well as expressions of their receptor genes (daf-2, vab-1, and/or mig-1), were dysregulated by the RNAi of daf-12, nhr-14, nhr-47, and nhr-12. Therefore, alteration in certain germline NHRs could mediate the induction of transgenerational nanoplastic toxicity by affecting secreted ligands and their receptors in the offspring of exposed organisms.
Collapse
Affiliation(s)
- Zhengying Liu
- Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Medical School, Southeast University, Nanjing 210009, China; (Z.L.); (Y.W.)
| | - Yuxing Wang
- Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Medical School, Southeast University, Nanjing 210009, China; (Z.L.); (Y.W.)
| | - Qian Bian
- Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China;
| | - Dayong Wang
- Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Medical School, Southeast University, Nanjing 210009, China; (Z.L.); (Y.W.)
- Shenzhen Ruipuxun Academy for Stem Cell & Regenerative Medicine, Shenzhen 518122, China
| |
Collapse
|